MANILA - A Philippine health official said Friday that a clinical trial for the Japanese anti-flu drug Avigan as a potential treatment for COVID-19 has yet to begin, correcting an announcement earlier this week by the nation's science secretary that it was already ongoing.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
